Explore

Streams

Products

About Index

Index

By TNW

Latterell Venture Partners

3866

Latterell Venture Partners

Follow us

Also headquartered in San Francisco

Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 13

Portfolio

Portfolio Tracker

Add info

$66,000,000 Venture capital (Series H)

Pulmonx Raises $66M in Financing

Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials

Viracta Therapeutics Closes Series D Financing

$65,000,000 Undisclosed

HK’s Ally Bridge Group leads $65m financing for US-based Pulmonx

VC-backed Aptinyx goes public

Stock markets Funding

$70,000,000 Venture capital (Series B)

,

| Aptinyx lands $70 mln Series B

$18,400,000 Venture capital (Series B)

Viracta nabs $18.4M, Soon-Shiong as vice chair in Series B

$65,000,000 Venture capital (Series A)

,

Naurex Spinout Aptinyx Banks 65 Million Series A to Advance Therapies for Neurological Disorders

Science Funding Health